carteolol has been researched along with dinoprost in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amano, S; Inoue, K; Inoue, Y; Kato, S; Okugawa, K; Oshika, T; Tomita, G | 1 |
Dorigo, MT; Dorigo, P; Floreani, M; Quintieri, L; Varani, K | 1 |
2 other study(ies) available for carteolol and dinoprost
Article | Year |
---|---|
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carteolol; Dinoprost; Drug Therapy, Combination; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Keratitis; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Risk Factors; Sulfonamides; Tears; Thiophenes; Timolol | 2003 |
Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Aorta; Carteolol; Dinoprost; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Male; Phenylephrine; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Vasodilation | 2008 |